Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
1
Artesian
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
Registers and programsofficial lists and records that name the company
Legal entity GenEmbryomics Limited its site
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Screen embryos for 400+ genetic conditions before pregnancy. Orchid's whole genome screening reads 99% of an embryo's genome — 100x more…
MyOme is a clinical whole genome analysis platform company helping families understand their risk for inherited diseases. As a leader in…
GeneticoVenture round $2.8M · 2 yr ago • Founded 2012 • 11-50 employees • 4 roles
Genetico is a Russian centre for genetics and reproductive medicine offering genetic testing. Patients can take genetic tests and consult a…
Human LongevityVenture round $32M · 3 yr ago • Founded 2013 • 51-200 employees • 3 roles
The most comprehensive executive health assessment — full-body MRI, whole genome sequencing, 120+ biomarkers & AI analysis in one visit…
Feanix Autopilot combines whole-genome sequencing, DairyComp, EZfeed, milk checks, feed costs, health records, and real farm performance…
3X4 GeneticsFounded 2018
3X4 Genetics offers DNA genetic testing that tells you everything you need to know about your body. Learn how to manage your health with…

Overview

The Miracle of Life - Perfected.. Panacea GenomeScreen™ advances Preimplantation Genetic Testing with Whole Genome Sequencing (PGT-WGS), combining PGT-A, PGT-M, PGT-SR, and screening 3,200+ critical genes for inherited and new mutations. Exclusive to GenEmbryomics.

News

News YahooFinance 4 months ago
CORRECTION: GenEmbryomics and Genomic Prediction Launch XGEN PGT-X
HACKETTSTOWN, N.J., May 05, 2026 (GLOBE NEWSWIRE) -- CORRECTION NOTICE: The press release issued by GenEmbryomics Limited on 30 April 2026, titled
Read more
Report
Report
News menafn 3 years ago
Genembryomics Engages Wallachbeth To Pursue Listing On A Us National Stock Exchange
Genembryomics Engages Wallachbeth To Pursue Listing On A Us National Stock Exchange. MELBOURNE, Australia, July 19, 2023 (GLOBE NEWSWIRE) -- GenEmbryomics, a medical genetics company with world leading intellectual property, today announced that it has re
Read more
Report
News FinanzNachrichten.de 3 years ago
GenEmbryomics: Reproductive Geneticists Gathered in Paris Present the First-Ever Whole Genome Sequencing Test in Embryos
Dr. Santiago Munné, a pioneer in preimplantation genetic diagnosis, presented the new test at the PGDIS Conference The novel laboratory test will not only detect genes inherited from parents, but will
Read more
Report